Advarra Executive and Leadership Team

Gadi Saarony, the Chief Executive Officer at Advarra, directs the overarching corporate strategy to advance clinical research standards. Saarony architects the long-term vision for integrating safety, technology, and collaboration across the life sciences sector. By aligning the organization with the needs of CROs, research sites, and investigators, the Chief Executive Officer ensures that clinical trials become safer, smarter, and faster. Gadi Saarony maintains a focus on scaling operations to meet the complex demands of global research environments. This leadership role involves constant engagement with the Board to drive sustainable growth and market impact. Through the implementation of innovative review solutions, the Chief Executive Officer strengthens the company's position as a leader in research compliance. Ultimately, Saarony fosters a culture of excellence that supports the mission of protecting trial participants while accelerating the delivery of life-saving medical advancements to the broader healthcare market.

Dwight Van Inwegen, the Chief Financial Officer at Advarra, directs the financial planning and fiscal health of the organization. Van Inwegen manages capital allocation to support the development of innovative technologies and the expansion of research consulting services. By overseeing financial reporting and risk management, the Chief Financial Officer ensures that the company maintains the stability required to serve life sciences companies and research sites effectively. Dwight Van Inwegen collaborates with the executive team to evaluate investment opportunities that align with the long-term growth strategy. This role involves monitoring market trends to optimize revenue streams and ensure the efficient use of resources across all business units. Through rigorous financial oversight, the Chief Financial Officer supports the company's mission to advance clinical research. Van Inwegen maintains a focus on fiscal discipline, providing the necessary foundation for the organization to continue delivering high-value solutions to the global clinical trial community.

Scott Uebele, the Chief Operating Officer at Advarra, executes the daily operational strategies that sustain the company's research support services. Uebele manages the internal processes that connect life sciences companies with research sites, ensuring seamless collaboration and high-quality service delivery. By overseeing the execution of trusted review solutions, the Chief Operating Officer maintains the integrity and safety of clinical trials. Scott Uebele drives efficiency across all departments to ensure that research performance remains optimized for clients. This leadership role involves coordinating with other C-suite members to align operational output with the broader corporate mission. Through the management of complex service delivery models, the Chief Operating Officer supports the expansion of research capabilities across diverse geographic regions. Uebele focuses on streamlining workflows to reduce trial timelines, ultimately ensuring that the organization provides the necessary resources for investigators to conduct research safely and effectively in a competitive market.

Jeff Sidell, the Chief Technology Officer at Advarra, architects the digital infrastructure required to modernize clinical research workflows. Sidell drives the development of innovative technologies that empower research sites and investigators to manage complex trial data with precision. By overseeing the integration of advanced software solutions, the Chief Technology Officer ensures that all platforms meet rigorous compliance standards while enhancing operational speed. Jeff Sidell collaborates with internal product teams to translate industry needs into scalable technical capabilities that support life sciences companies. This role involves managing the security and reliability of digital assets to safeguard sensitive trial information. Through the deployment of cutting-edge tools, the Chief Technology Officer optimizes research performance across North American and international markets. Sidell maintains a focus on continuous improvement, ensuring that the technological foundation remains robust enough to handle the evolving demands of the global clinical research ecosystem.

Allie Rozanski, the Chief Revenue Officer & Client Executive at Advarra, drives the commercial strategy and client engagement initiatives. Rozanski architects the outreach programs that connect life sciences companies and CROs with the company's integrated research solutions. By overseeing the sales and account management teams, the Chief Revenue Officer & Client Executive ensures that clients receive tailored support to optimize their clinical trial performance. Allie Rozanski fosters deep-seated connections across the industry to expand the company's market presence and influence. This leadership role involves identifying new opportunities for collaboration and ensuring that client needs remain at the forefront of the business model. Through the management of strategic partnerships, the Chief Revenue Officer & Client Executive supports the company's growth objectives while maintaining a focus on participant safety. Rozanski directs the efforts to deliver value-driven solutions, ensuring that the organization remains the preferred partner for research sites and investigators worldwide.